{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:39:12Z","timestamp":1792841952632,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015666","name":"Aksum University","doi-asserted-by":"publisher","award":["AKUR\/L\/002\/24"],"award-info":[{"award-number":["AKUR\/L\/002\/24"]}],"id":[{"id":"10.13039\/100015666","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/003659f07","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.brachy.2026.07.172","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:57:30Z","timestamp":1789531050000},"page":"897-906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dosimetric and therapeutic effectiveness of high-dose-rate radionuclide sources in breast cancer brachytherapy: A systematic review"],"prefix":"10.1016","volume":"25","author":[{"given":"Tsige","family":"Gebremariam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teweldebrhan","family":"Gebru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brhanu","family":"Tsegaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit","family":"Brhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsegaye","family":"Gebremichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebiat","family":"Zerabruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.brachy.2026.07.172_bib0001","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1118\/1.3301607","article-title":"Monte Carlo characterization of a new Yb-169 high dose rate source for brachytherapy application","volume":"37","author":"Cazeca","year":"2010","journal-title":"Med Phys"},{"issue":"3","key":"10.1016\/j.brachy.2026.07.172_bib0002","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.brachy.2023.02.006","article-title":"A single-institution retrospective study of three-fraction HDR accelerated partial breast irradiation","volume":"22","author":"Chung","year":"2023","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.brachy.2026.07.172_bib0003","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement","volume":"7","author":"Correa","year":"2017","journal-title":"Pract Rad Oncol"},{"key":"10.1016\/j.brachy.2026.07.172_bib0004","article-title":"Isolating the impact of tissue heterogeneities in high dose rate brachytherapy treatment of the breast","volume":"33","author":"Faucher","year":"2025","journal-title":"Phys Imaging Rad Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2026.07.172_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5114\/jcb.2018.74327","article-title":"A comparative assessment of inhomogeneity and finite patient dimension effects in 60Co and 192Ir high-dose-rate brachytherapy","volume":"10","author":"Fotina","year":"2018","journal-title":"J Contemp Brachyther"},{"issue":"1","key":"10.1016\/j.brachy.2026.07.172_bib0006","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2005.06.016","article-title":"Monte Carlo calculation of the TG-43 dosimetric parameters of a new BEBIG Ir-192 HDR source","volume":"76","author":"Granero","year":"2005","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.brachy.2026.07.172_bib0007","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1118\/1.2759602","article-title":"Dosimetric study of a new Co-60 source used in brachytherapy","volume":"34","author":"Granero","year":"2007","journal-title":"Med Phys"},{"issue":"9804","key":"10.1016\/j.brachy.2026.07.172_bib0008","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Group","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.brachy.2026.07.172_bib0009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5114\/jcb.2025.151229","volume":"17","author":"Kapoor","year":"2025","journal-title":"J Contemp Brachyther"},{"issue":"12","key":"10.1016\/j.brachy.2026.07.172_bib0010","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1118\/1.2392408","article-title":"A dosimetric comparison of and for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities","volume":"33","author":"Lymperopoulou","year":"2006","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.brachy.2026.07.172_bib0011","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1118\/1.2147767","article-title":"Monte Carlo characterization of an ytterbium-169 high dose rate brachytherapy source with analysis of statistical uncertainty","volume":"33","author":"Medich","year":"2006","journal-title":"Med Phys"},{"issue":"2","key":"10.1016\/j.brachy.2026.07.172_bib0012","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1118\/1.597458","article-title":"Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43","volume":"22","author":"Nath","year":"1995","journal-title":"Med Phys"},{"issue":"5","key":"10.1016\/j.brachy.2026.07.172_bib0013","first-page":"413","article-title":"Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer","volume":"54","author":"Neumanova","year":"2007","journal-title":"Neoplasma"},{"key":"10.1016\/j.brachy.2026.07.172_bib0014","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.brachy.2026.07.172_bib0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.brachy.2026.01.001","article-title":"Accelerated partial breast irradiation with high-dose-rate multicatheter brachytherapy: 30-year results of a phase 2 clinical trial","volume":"25","author":"Polg\u00e1r","year":"2026","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.brachy.2026.07.172_bib0016","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.radonc.2010.01.014","volume":"94","author":"Polg\u00e1r","year":"2010","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.brachy.2026.07.172_bib0017","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ad3dbd","article-title":"Deep learning for high-resolution dose prediction in high dose rate brachytherapy for breast cancer treatment","volume":"69","author":"Quetin","year":"2024","journal-title":"Phys Med Biol"},{"issue":"3","key":"10.1016\/j.brachy.2026.07.172_bib0018","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations","volume":"31","author":"Rivard","year":"2004","journal-title":"Med Phys"},{"issue":"9","key":"10.1016\/j.brachy.2026.07.172_bib0019","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/acm2.13347","article-title":"Evaluation of dosimetric functions for a new 169Yb HDR brachytherapy source","volume":"22","author":"Safaeipour","year":"2021","journal-title":"J Appl Clin Med Phys"},{"issue":"4","key":"10.1016\/j.brachy.2026.07.172_bib0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5114\/jcb.2024.143609","article-title":"Dosimetric evaluation and Monte Carlo simulation of a new proposed surface brachytherapy mould","volume":"16","author":"Salamat","year":"2024","journal-title":"J Contemp Brachyther"},{"issue":"2","key":"10.1016\/j.brachy.2026.07.172_bib0021","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12282-025-01674-x","article-title":"Long-term local control and cosmesis of perioperative interstitial brachytherapy for partial breast irradiation following breast-conserving surgery","volume":"32","author":"Sato","year":"2025","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.brachy.2026.07.172_bib0022","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brachy.2017.09.004","article-title":"The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation","volume":"17","author":"Shah","year":"2018","journal-title":"Brachytherapy"},{"issue":"6","key":"10.1016\/j.brachy.2026.07.172_bib0023","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5114\/jcb.2017.72607","article-title":"Current status of brachytherapy in cancer treatment\u2013short overview","volume":"9","author":"Skowronek","year":"2017","journal-title":"J Contemp Brachyther"},{"issue":"3","key":"10.1016\/j.brachy.2026.07.172_bib0024","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.radonc.2018.04.009","article-title":"ESTRO-ACROP guideline: interstitial multi-catheter breast brachytherapy as accelerated partial breast irradiation alone or as boost\u2013GEC-ESTRO Breast Cancer Working Group practical recommendations","volume":"128","author":"Strnad","year":"2018","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.brachy.2026.07.172_bib0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1470-2045(23)00018-9","article-title":"Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial","volume":"24","author":"Strnad","year":"2023","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.brachy.2026.07.172_bib0026","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA"},{"issue":"3","key":"10.1016\/j.brachy.2026.07.172_bib0027","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.semradonc.2014.02.007","article-title":"Magnetic resonance image guided brachytherapy","volume":"24","author":"Tanderup","year":"2014","journal-title":"Semin Rad Oncol"},{"issue":"11","key":"10.1016\/j.brachy.2026.07.172_bib0028","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1118\/1.2987676","article-title":"EGSnrc Monte Carlo calculated dosimetry parameters for and brachytherapy sources","volume":"35","author":"Taylor","year":"2008","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.brachy.2026.07.172_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/jcb.2023.125579","article-title":"HDR-brachytherapy for accelerated partial breast irradiation: long-term experience from a Japanese institution","volume":"15","author":"Yoshida","year":"2023","journal-title":"J Contemp Brachyther"},{"issue":"6","key":"10.1016\/j.brachy.2026.07.172_bib0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5114\/jcb.2015.56766","article-title":"Evaluation of BEBIG HDR 60 Co system for non-invasive image-guided breast brachytherapy","volume":"7","author":"Zehtabian","year":"2015","journal-title":"J Contemp Brachyther"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472126002795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472126002795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:33:55Z","timestamp":1792841635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472126002795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1538472126002795"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2026.07.172","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric and therapeutic effectiveness of high-dose-rate radionuclide sources in breast cancer brachytherapy: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2026.07.172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}